Case Report

Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Volume: 4 Number: 1 May 14, 2024
EN

Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Abstract

This is the report of three cases with diagnosis of Lymphoma who has pancreatic involvement as well as disseminated disease presentation as demonstrated by F-18 FDG PET/CT.

Keywords

References

  1. Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Clin Nucl Med. 2007 Apr;32(4):282-5. doi: 10.1097/01.rlu.0000257295.12017.ab.
  2. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
  3. Nanni C, Romagnoli R, Rambaldi I, Caroli P, Matteucci F, Ambrosini V, Re G, Fanti S. FDG PET/CT in autoimmune pancreatitis. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1264-5. doi: 10.1007/s00259-014-2699-5.
  4. Santhosh S, Bhattacharya A, Harisankar CN, Kochhar R, Mittal BR. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Clin Nucl Med. 2013 Nov;38(11):e423-5. doi: 10.1097/RLU.0b013e31827086b5.
  5. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2088-95. doi: 10.1007/s00259-007-0562-7.
  6. Dong A, Cui Y, Gao L, Wang Y, Zuo C, Yang J. Patterns of FDG uptake in pancreatic non-Hodgkin's lymphoma lesions. Abdom Imaging. 2014 Feb;39(1):175-86. doi: 10.1007/s00261-013-0041-5.
  7. Schaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D., von Schulthess, G. K., & Goerres, G. W. (2004). Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?. Radiology, 232(3), 823–829. https://doi.org/10.1148/radiol.2323030985
  8. Zhang, J., Shao, C., Wang, J., Cheng, C., Zuo, C., Sun, G., Cui, B., Dong, A., Liu, Q., & Kong, L. (2013). Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings. Abdominal imaging, 38(3), 543–549. https://doi.org/10.1007/s00261-012-9966-3

Details

Primary Language

English

Subjects

Gastroenterology and Hepatology, Nuclear Medicine, Haematological Tumours, Oncology and Carcinogenesis (Other)

Journal Section

Case Report

Publication Date

May 14, 2024

Submission Date

April 4, 2024

Acceptance Date

May 14, 2024

Published in Issue

Year 2024 Volume: 4 Number: 1

APA
Koç, Z. P., Özcan, P. P., & Yaraş, S. (2024). Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging, 4(1), 7-10. https://izlik.org/JA47WE35ZL
AMA
1.Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2024;4(1):7-10. https://izlik.org/JA47WE35ZL
Chicago
Koç, Zehra Pınar, Pınar Pelin Özcan, and Serkan Yaraş. 2024. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography”. Molecular Oncologic Imaging 4 (1): 7-10. https://izlik.org/JA47WE35ZL.
EndNote
Koç ZP, Özcan PP, Yaraş S (May 1, 2024) Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging 4 1 7–10.
IEEE
[1]Z. P. Koç, P. P. Özcan, and S. Yaraş, “Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography”, Molecular Oncologic Imaging, vol. 4, no. 1, pp. 7–10, May 2024, [Online]. Available: https://izlik.org/JA47WE35ZL
ISNAD
Koç, Zehra Pınar - Özcan, Pınar Pelin - Yaraş, Serkan. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography”. Molecular Oncologic Imaging 4/1 (May 1, 2024): 7-10. https://izlik.org/JA47WE35ZL.
JAMA
1.Koç ZP, Özcan PP, Yaraş S. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging. 2024;4:7–10.
MLA
Koç, Zehra Pınar, et al. “Pancreatic Involvement of Lymphoma As Determined by F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography”. Molecular Oncologic Imaging, vol. 4, no. 1, May 2024, pp. 7-10, https://izlik.org/JA47WE35ZL.
Vancouver
1.Zehra Pınar Koç, Pınar Pelin Özcan, Serkan Yaraş. Pancreatic involvement of Lymphoma as determined by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Molecular Oncologic Imaging [Internet]. 2024 May 1;4(1):7-10. Available from: https://izlik.org/JA47WE35ZL